671
Participants
Start Date
June 3, 2013
Primary Completion Date
July 9, 2015
Study Completion Date
July 9, 2015
Ranibizumab
Intravitreal injections of 0.5 mg Ranibizumab
Novartis Investigative Site, Lausanne
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Vienna
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Geneva
Novartis Investigative Site, Bern
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Zurich
Novartis Investigative Site, Zalaegerszeg
Novartis Investigative Site, Santiago de Compostela
Novartis Investigative Site, Glyfada
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Madrid
Novartis Investigative Site, Oviedo
Novartis Investigative Site, Udine
Novartis Investigative Site, Ioannina
Novartis Investigative Site, Bilbao
Novartis Investigative Site, Münster
Novartis Investigative Site, Münster
Novartis Investigative Site, Kaunas
Novartis Investigative Site, Florence
Novartis Investigative Site, Cologne
Novartis Investigative Site, Bonn
Novartis Investigative Site, Darmstadt
Novartis Investigative Site, Kuopio
Novartis Investigative Site, Paris
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, München
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Trenčín
Novartis Investigative Site, Regensburg
Novartis Investigative Site, Nitra
Novartis Investigative Site, Bogotá
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Ciudad Autonoma de Bs As
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Halifax
Novartis Investigative Site, London
Novartis Investigative Site, Ottawa
Novartis Investigative Site, Boisbriand
Novartis Investigative Site, Sherbrooke
Novartis Investigative Site, Medellín
Novartis Investigative Site, Olomouc
Novartis Investigative Site, Brno
Novartis Investigative Site, Hradec Králové
Novartis Investigative Site, Prague
Novartis Investigative Site, HUS
Novartis Investigative Site, Chemnitz
Novartis Investigative Site, Ampelokipoi
Novartis Investigative Site, Athens
Novartis Investigative Site, Guatemala City
Novartis Investigative Site, Guatemala City
Novartis Investigative Site, Szeged
Novartis Investigative Site, Veszprém
Novartis Investigative Site, Dublin
Novartis Investigative Site, Waterford
Novartis Investigative Site, Vilnius
Novartis Investigative Site, Mexico City
Novartis Investigative Site, 's-Hertogenbosch
Novartis Investigative Site, Nijmegen
Novartis Investigative Site, Rotterdam
Novartis Investigative Site, Panama City
Novartis Investigative Site, Coimbra
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Porto
Novartis Investigative Site, Zvolen
Novartis Investigative Site, Žilina
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Linköping
Novartis Investigative Site, Ankara
Novartis Investigative Site, Ankara
Novartis Investigative Site, Frimley
Novartis Investigative Site, Belfast
Novartis Investigative Site, Bristol
Novartis Investigative Site, Cheshire
Novartis Investigative Site, Derby
Novartis Investigative Site, Gloucester
Novartis Investigative Site, Great Yarmouth
Novartis Investigative Site, Guildford, Surrey
Novartis Investigative Site, Hull
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, Middlesbrough
Novartis Investigative Site, Rugby
Novartis Investigative Site, Southampton
Novartis Investigative Site, Wolverhampton
Novartis Investigative Site, York
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY